Basit öğe kaydını göster

dc.contributor.authorKara, Murat
dc.contributor.authorKaplan, Mehmet
dc.contributor.authorBozgeyik, İbrahim
dc.contributor.authorÖzcan, Önder
dc.contributor.authorÇelik, Özgür İlhan
dc.contributor.authorBozgeyik, Esra
dc.contributor.authorYumrutaş, Önder
dc.date.accessioned2020-11-20T15:02:09Z
dc.date.available2020-11-20T15:02:09Z
dc.date.issued2016
dc.identifier.issn0378-1119
dc.identifier.issn1879-0038
dc.identifier.urihttps://doi.org/10.1016/j.gene.2016.05.006
dc.identifier.urihttps://hdl.handle.net/20.500.12809/2402
dc.description0000-0001-8252-3339en_US
dc.descriptionWOS: 000377827600009en_US
dc.descriptionPubMed ID: 27155522en_US
dc.description.abstractBreast cancer is major public health problem predominantly effects female population. Current therapeutic approaches to deal with breast cancer are still lack of effectiveness. Thus, identifying/developing novel strategies to fight against breast cancer is very important. The frequent deletions at 8p21.3-22 chromosomal location nearby D8S254 marker enabled the discovery of a novel tumor suppressor gene, MTUS1. Subsequently, MTUS1 was demonstrated to be less expressed in a variety cancer types including breast cancer. Also, it is obvious that gene expression is widely regulated by miRNAs. Here, we aimed to report differential expression of MTUS1 and its regulatory miRNAs in breast cancer and fibroadenoma tissues. Dynamic analysis of MTUS1 expression levels and its miRNAs regulators were attained by Fluidigm 96 x 96 Dynamic Array Expression chips and reactions were performed in Fluidigm BioMark (TM) HD System qPCR. Consequently, MTUS1 mRNA levels were significantly diminished in breast cancer tissues and elevated in fibroadenoma tissues. Also, among MTUS1 targeting miRNAs, miR-183-5p was identified to be overexpressed in breast cancer and down-regulated in fibroadenoma tissues. Also, expression levels of MTUS1 and miR-183-5p were well correlated with clinical parameters. In particular, MTUS1 expression was found to be diminished and miR-183-5p expression was elevated with the advancing stage. In conclusion, as a potential therapeutic target, miR-183-5p can be a chief regulator of MTUS1 and MTUS1-miR-183-5p axis may have significant influence in the pathology of breast cancer. (C) 2016 Elsevier B.V. All rights reserved.en_US
dc.item-language.isoengen_US
dc.publisherElsevier Science Bven_US
dc.item-rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBreast Canceren_US
dc.subjectFibroadenomaen_US
dc.subjectMTUS1en_US
dc.subjectMirnaen_US
dc.subjectMir-183-5pen_US
dc.subjectLet-7en_US
dc.titleMTUS1 tumor suppressor and its miRNA regulators in breast canceren_US
dc.item-typearticleen_US
dc.contributor.departmentMÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorÖzcan, Önder
dc.contributor.institutionauthorÇelik, Özgür İlhan
dc.identifier.doi10.1016/j.gene.2016.05.006
dc.identifier.volume587en_US
dc.identifier.issue2en_US
dc.identifier.startpage173en_US
dc.identifier.endpage177en_US
dc.relation.journalGeneen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster